BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34325966)

  • 1. Prognostic impact of tumor vascularity on CT in resectable intrahepatic cholangiocarcinoma.
    Park HM; Jang HY; Lee DE; Kang MJ; Han SS; Kim SW; Park SJ
    HPB (Oxford); 2022 Mar; 24(3):359-369. PubMed ID: 34325966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass-forming intrahepatic cholangiocarcinoma with marked enhancement on arterial-phase computed tomography reflects favorable surgical outcomes.
    Ariizumi S; Kotera Y; Takahashi Y; Katagiri S; Chen IP; Ota T; Yamamoto M
    J Surg Oncol; 2011 Aug; 104(2):130-9. PubMed ID: 21448898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The favorable prognosis after operative resection of hypervascular intrahepatic cholangiocarcinoma: A clinicopathologic and immunohistochemical study.
    Türkoğlu MA; Yamamoto Y; Sugiura T; Okamura Y; Ito T; Ashida R; Uemura S; Miyata T; Kakuda Y; Nakanuma Y; Uesaka K
    Surgery; 2016 Sep; 160(3):683-90. PubMed ID: 27155908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors of recurrent intrahepatic cholangiocarcinoma after hepatectomy: A retrospective study.
    Yuan ZB; Fang HB; Feng QK; Li T; Li J
    World J Gastroenterol; 2022 Apr; 28(15):1574-1587. PubMed ID: 35582131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial enhancement pattern predicts survival in patients with resectable and unresectable intrahepatic cholangiocarcinoma.
    Panettieri E; Maki H; Kim BJ; Kang HC; Cox V; Vega EA; Mizuno T; Pant S; Javle M; Vauthey JN; Kawaguchi Y
    Surg Oncol; 2022 Mar; 40():101696. PubMed ID: 34995974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of body mass index on tumor recurrence among patients undergoing curative-intent resection of intrahepatic cholangiocarcinoma- a multi-institutional international analysis.
    Merath K; Mehta R; Hyer JM; Bagante F; Sahara K; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Weiss MJ; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Ejaz A; Pawlik TM
    Eur J Surg Oncol; 2019 Jun; 45(6):1084-1091. PubMed ID: 30871884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrahepatic cholangiocarcinoma: relationship between tumor imaging enhancement by measuring attenuation and clinicopathologic characteristics.
    Nanashima A; Abo T; Murakami G; Matsumoto A; Tou K; Takeshita H; Kunizaki M; Hidaka S; Sakamoto I; Hayashi H; Fukuda T; Kudo T; Nagayasu T
    Abdom Imaging; 2013 Aug; 38(4):785-92. PubMed ID: 23232581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
    Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
    World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma.
    Hu LS; Zhang XF; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
    Ann Surg Oncol; 2019 Aug; 26(8):2549-2557. PubMed ID: 31020501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel prognostic system combining carbonic anhydrase II and preoperative CA19-9 for intrahepatic cholangiocarcinoma after curative resection.
    Zhang J; Huang Q; Yang Y; Zhang J; Fang X; Yang Y; Liang H; Wang W; Wang Y
    Cancer; 2023 Apr; 129(7):1030-1040. PubMed ID: 36625486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of surgical management for recurrent intrahepatic cholangiocarcinoma: A multi-institutional study by the Okayama Study Group of HBP surgery.
    Kojima T; Umeda Y; Fuji T; Niguma T; Sato D; Endo Y; Sui K; Inagaki M; Oishi M; Ota T; Hioki K; Matsuda T; Aoki H; Hirai R; Kimura M; Yagi T; Fujiwara T
    PLoS One; 2020; 15(9):e0238392. PubMed ID: 32881910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma.
    Nickkholgh A; Ghamarnejad O; Khajeh E; Tinoush P; Bruckner T; Kulu Y; Mieth M; Goeppert B; Roessler S; Weiss KH; Hoffmann K; Büchler MW; Mehrabi A
    BJS Open; 2019 Dec; 3(6):793-801. PubMed ID: 31832586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting risk of recurrence after resection of stage I intrahepatic cholangiocarcinoma.
    Kawashima J; Sahara K; Shen F; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Cauchy F; Koerkamp BG; Matsuyama R; Endo I; Pawlik TM
    J Gastrointest Surg; 2024 Jan; 28(1):18-25. PubMed ID: 38353070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma.
    Asayama Y; Yoshimitsu K; Irie H; Tajima T; Nishie A; Hirakawa M; Nakayama T; Kakihara D; Taketomi A; Aishima S; Honda H
    Radiology; 2006 Jan; 238(1):150-5. PubMed ID: 16304089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma.
    Hu LS; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
    J Surg Oncol; 2019 Jan; 119(1):21-29. PubMed ID: 30466151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes for Patients with Recurrent Intrahepatic Cholangiocarcinoma After Surgery.
    Park HM; Yun SP; Lee EC; Lee SD; Han SS; Kim SH; Park SJ
    Ann Surg Oncol; 2016 Dec; 23(13):4392-4400. PubMed ID: 27581609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the Outcomes of Intrahepatic Cholangiocarcinoma After Ultrasound-Guided Percutaneous Microwave Ablation Based on Albumin-Bilirubin Grade.
    Yang H; Cheng Z; Han Z; Liu F; Yu X; Yu J; Liang P
    Cardiovasc Intervent Radiol; 2021 Feb; 44(2):261-270. PubMed ID: 33057809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of preoperative geriatric nutritional risk index in intrahepatic cholangiocarcinoma after hepatectomy: a single‑center retrospective cohort study.
    Ogawa D; Miyata T; Yumoto S; Shiraishi Y; Matsumoto T; Takematsu T; Tsukamoto M; Nakagawa S; Mima K; Nitta H; Hayashi H; Baba H
    Langenbecks Arch Surg; 2024 Jan; 409(1):47. PubMed ID: 38267769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrahepatic cholangiocarcinoma: Introducing the preoperative prediction score based on preoperative imaging.
    Bartsch F; Hahn F; Müller L; Baumgart J; Hoppe-Lotichius M; Kloeckner R; Lang H
    Hepatobiliary Pancreat Dis Int; 2021 Jun; 20(3):262-270. PubMed ID: 32861577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma: Considering Alternative Treatment Approaches.
    Tsilimigras DI; Sahara K; Wu L; Moris D; Bagante F; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Soubrane O; Koerkamp BG; Moro A; Sasaki K; Aucejo F; Zhang XF; Matsuyama R; Endo I; Pawlik TM
    JAMA Surg; 2020 Sep; 155(9):823-831. PubMed ID: 32639548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.